BRSF (Brain Scientific) ROCE %: -22.53% (As of Dec. 2022)


BRSF Brain Scientific Inc BRSF
10 GF Score
Price $0.00
View Full Analysis

What is Brain Scientific ROCE %?

Brain Scientific BRSF 10 ROCE % is -22.53% as of Dec. 2022. GuruFocus rates BRSF with a GF Score™ of 10/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Brain Scientific's annualized ROCE % for the quarter that ended in Dec. 2022 was -22.53%.

Brain Scientific  (OTCPK:BRSF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Brain Scientific ROCE % Related Terms

Brain Scientific ROCE % Historical Data

* Premium members only.

The historical data trend for Brain Scientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brain Scientific ROCE % Chart

Brain Scientific Annual Data
Trend Dec21 Dec22
ROCE %
-94.60 -130.85

Brain Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
ROCE % Get a 7-Day Free Trial -228.10 -87.46 -41.26 -210.88 -22.53
BRSF
10GF Score
Brain Scientific Inc BRSF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brain Scientific ROCE % Calculation

Brain Scientific's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-8.738/( ( (13.375 - 4.344) + (11.744 - 7.419) )/ 2 )
=-8.738/( (9.031+4.325)/ 2 )
=-8.738/6.678
=-130.85 %

Brain Scientific's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2022 )  (Q: Sep. 2022 )(Q: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2022 )  (Q: Sep. 2022 )(Q: Dec. 2022 )
=-1.3/( ( (14.022 - 6.806) + (11.744 - 7.419) )/ 2 )
=-1.3/( ( 7.216 + 4.325 )/ 2 )
=-1.3/5.7705
=-22.53 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2022) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -22.53% mean?
Brain Scientific (BRSF) has a ROCE % of -22.53% as of Dec. 2022.
Is Brain Scientific's ROCE % too high?
Brain Scientific's current ROCE % is -22.53%. Overall, Brain Scientific has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Brain Scientific's ROCE % compare to MOTS and BRSF?
Brain Scientific's ROCE % of -22.53% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Brain Scientific's current ROCE % is -22.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brain Scientific stock overvalued right now?
Brain Scientific (BRSF) has a current ROCE % of -22.53%. The current ROCE % is -22.53%. Brain Scientific's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Brain Scientific (BRSF), the current ROCE % is -22.53% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brain Scientific Business Description

Address 6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
10GF Score

Get the complete analysis for BRSF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price